Meta-Antenna and Energy harvesting/storage modules development for autarkic sensors arrays
METATHERM aims to create a self-sustaining energy harvesting and communication system for sensor arrays using innovative metamaterial antennas and ionic thermoelectric devices.
Projectdetails
Introduction
METATHERM will demonstrate a versatile energy harvesting and communication system for unattended environment sensor arrays, allowing the development of maintenance-free and autarkic operation devices. The novelty builds up from several different innovations, the main one being the microwave antenna, based on epsilon engineering using metamaterials. This allows the antenna to show extremely high gain and extreme compactness [FETOPEN Project NANOPOLY].
Energy Efficiency
The energy efficiency of the antenna allows the electrical power needs to be decreased accordingly. This enables the consideration of novel energy harvesting technologies to be used to power the system. In METATHERM, the energy of the sun is harvested using a novel ionic thermoelectric device.
Ionic Thermoelectric Device
This technology is based on ion migration under a thermal gradient and shows a higher Seebeck coefficient than usual tellurium-based semiconductors without the use of rare or toxic elements. This is a significant advantage in the context of the rapidly growing energy demand for IoT and mobile electronic systems.
Energy Storage
Used in addition to a supercapacitor to store the electrical energy and a thermal energy storage device, the METATHERM platform will allow continuous operation of the device day and night. Moreover, due to the similarity in device structure between the ionic thermoelectric (iTE) device and the supercapacitor, METATHERM will benefit from the manufacturing know-how of the latter.
Expected Outcomes
A substantial maturity level increase is then expected for the iTE devices. Finally, the project aims to develop a platform integrating all these technologies into a single device and exploring its potential applications.
Market Fit
To ensure market fit, the project plans a three-phase exploitation plan:
- Gathering potential user interest at the beginning of the project.
- Selecting the most promising applications at the demonstrator design stage.
- Producing a transfer plan at the end of the project.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.498.710 |
Totale projectbegroting | € 2.498.710 |
Tijdlijn
Startdatum | 1-4-2022 |
Einddatum | 30-9-2025 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- BERLINER NANOTEST UND DESIGN GMBHpenvoerder
- THALES
- IDRYMA TECHNOLOGIAS KAI EREVNAS
- LINKOPINGS UNIVERSITET
- LIGNA ENERGY AB
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
COOLing for Electricity Production: Battery-free TechnologyCOOLed aims to develop a battery-free technology using 3D polymer metamaterials and 2D transition metal selenides to generate electricity from cold space for IoT devices in smart cities. | ERC COG | € 2.000.000 | 2023 | Details |
Origami inspired thermoelectric generators by printing and foldingORTHOGONAL aims to develop cost-effective, scalable thermoelectric generators using printable nanocomposite materials to harvest low-temperature waste heat for powering future sensor devices. | ERC ADG | € 2.410.155 | 2023 | Details |
Microwave Metadevices based on Electrically Tunable organic Ion-electron ConductorsMiMETIC aims to develop electrically reconfigurable microwave devices using organic electrochemical transistors to enhance wireless communication and bioelectronics through innovative metadevice tuning. | ERC STG | € 2.216.250 | 2024 | Details |
Tellurium-free Thermoelectric Technology for Near-room-temperature ApplicationsDeveloping next-generation thermoelectric modules using Mg-based compounds to achieve high efficiency and sustainability, surpassing current bismuth telluride technology for diverse applications. | ERC STG | € 1.498.895 | 2024 | Details |
COOLing for Electricity Production: Battery-free Technology
COOLed aims to develop a battery-free technology using 3D polymer metamaterials and 2D transition metal selenides to generate electricity from cold space for IoT devices in smart cities.
Origami inspired thermoelectric generators by printing and folding
ORTHOGONAL aims to develop cost-effective, scalable thermoelectric generators using printable nanocomposite materials to harvest low-temperature waste heat for powering future sensor devices.
Microwave Metadevices based on Electrically Tunable organic Ion-electron Conductors
MiMETIC aims to develop electrically reconfigurable microwave devices using organic electrochemical transistors to enhance wireless communication and bioelectronics through innovative metadevice tuning.
Tellurium-free Thermoelectric Technology for Near-room-temperature Applications
Developing next-generation thermoelectric modules using Mg-based compounds to achieve high efficiency and sustainability, surpassing current bismuth telluride technology for diverse applications.